1-5 of 5
Thomas Moritz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reciprocal Relationship between O6-Methylguanine-DNA Methyltransferase P140K Expression Level and Chemoprotection of Hematopoietic Stem Cells

Michael D. Milsom, Moran Jerabek-Willemsen, Chad E. Harris, Axel Schambach, Emily Broun, Jeff Bailey, Michael Jansen, David Schleimer, Kalpana Nattamai, Jamie Wilhelm, Amanda Watson, Hartmut Geiger, Geoffrey P. Margison, Thomas Moritz, Christopher Baum, Jürgen Thomale, David A. Williams
Journal: Cancer Research
Cancer Res (2008) 68 (15): 6171–6180.
https://doi.org/10.1158/0008-5472.CAN-08-0320
Published: 01 August 2008
View article titled, Reciprocal Relationship between <em>O</em><sup>6</sup>-Methylguanine-DNA Methyltransferase P140K Expression Level and Chemoprotection of Hematopoietic Stem Cells
Open the PDF for Reciprocal Relationship between <em>O</em><sup>6</sup>-Methylguanine-DNA Methyltransferase P140K Expression Level and Chemoprotection of Hematopoietic Stem Cells in another window
Includes: Supplementary data
Journal Articles

A Novel Nonobese Diabetic/Severe Combined Immunodeficient Xenograft Model for Chronic Lymphocytic Leukemia Reflects Important Clinical Characteristics of the Disease

Jan Dürig, Peter Ebeling, Florian Grabellus, Ursula R. Sorg, Michael Möllmann, Philipp Schütt, Joachim Göthert, Ludger Sellmann, Siegfried Seeber, Michael Flasshove, Ulrich Dührsen, Thomas Moritz
Journal: Cancer Research
Cancer Res (2007) 67 (18): 8653–8661.
https://doi.org/10.1158/0008-5472.CAN-07-1198
Published: 17 September 2007
View article titled, A Novel Nonobese Diabetic/Severe Combined Immunodeficient Xenograft Model for Chronic Lymphocytic Leukemia Reflects Important Clinical Characteristics of the Disease
Open the PDF for A Novel Nonobese Diabetic/Severe Combined Immunodeficient Xenograft Model for Chronic Lymphocytic Leukemia Reflects Important Clinical Characteristics of the Disease in another window
Includes: Supplementary data
Journal Articles

SPC2996, a novel mRNA antagonist targeting Bcl-2, is therapeutically active in a preclinical model of human chronic lymphocytic leukemia

Peter Ebeling, Phil Kearney, Jan Duerig, Thomas Moritz, Bo Hansen, Margit Wissenbach
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): LB-316.
Published: 01 May 2007
View article titled, SPC2996, a novel mRNA antagonist targeting Bcl-2, is therapeutically active in a preclinical model of human chronic lymphocytic leukemia
Journal Articles

Retrovirus-mediated Expression of a DNA Repair Protein in Bone Marrow Protects Hematopoietic Cells from Nitrosourea-induced Toxicity in Vitro and in Vivo

Thomas Moritz, William Mackay, Brian J. Glassner, David A. Williams, Leona Samson
Journal: Cancer Research
Cancer Res (1995) 55 (12): 2608–2614.
Published: 01 June 1995
View article titled, Retrovirus-mediated Expression of a DNA Repair Protein in Bone Marrow Protects Hematopoietic Cells from Nitrosourea-induced Toxicity <em>in Vitro</em> and <em>in Vivo</em>
Open the PDF for Retrovirus-mediated Expression of a DNA Repair Protein in Bone Marrow Protects Hematopoietic Cells from Nitrosourea-induced Toxicity <em>in Vitro</em> and <em>in Vivo</em> in another window
Journal Articles

Increased Survival and Multilineage Hematopoietic Protection from Delayed and Severe Myelosuppressive Effects of a Nitrosourea with Recombinant Interleukin-11

Rodney Maze, Thomas Moritz, David A. Williams
Journal: Cancer Research
Cancer Res (1994) 54 (18): 4947–4951.
Published: 01 September 1994
View article titled, Increased Survival and Multilineage Hematopoietic Protection from Delayed and Severe Myelosuppressive Effects of a Nitrosourea with Recombinant Interleukin-11
Open the PDF for Increased Survival and Multilineage Hematopoietic Protection from Delayed and Severe Myelosuppressive Effects of a Nitrosourea with Recombinant Interleukin-11 in another window